Home LiteratureArticle Details
PMID: 18380992 Published · ppublish English Journal Article Review

Gut microbiota and its possible relationship with obesity.

Mayo Clinic proceedings ·Vol. 83 ·No. 4 ·2008-04-00 ·Pages 460-9

DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE

Abstract

Obesity results from alterations in the body's regulation of energy intake, expenditure, and storage. Recent evidence, primarily from investigations in animal models, suggests that the gut microbiota affects nutrient acquisition and energy regulation. Its composition has also been shown to differ in lean vs obese animals and humans. In this article, we review the published evidence supporting the potential role of the gut microbiota in the development of obesity and explore the role that modifying the gut microbiota may play in its future treatment. Evidence suggests that the metabolic activities of the gut microbiota facilitate the extraction of calories from ingested dietary substances and help to store these calories in host adipose tissue for later use. Furthermore, the gut bacterial flora of obese mice and humans include fewer Bacteroidetes and correspondingly more Firmicutes than that of their lean counterparts, suggesting that differences in caloric extraction of ingested food substances may be due to the composition of the gut microbiota. Bacterial lipopolysaccharide derived from the intestinal microbiota may act as a triggering factor linking inflammation to high-fat diet-induced metabolic syndrome. Interactions among microorganisms in the gut appear to have an important role in host energy homeostasis, with hydrogen-oxidizing methanogens enhancing the metabolism of fermentative bacteria. Existing evidence warrants further investigation of the microbial ecology of the human gut and points to modification of the gut microbiota as one means to treat people who are over-weight or obese.

MeSH Terms
Animals Bacterial Physiological Phenomena Energy Metabolism Humans Intestines/microbiology Obesity/metabolism,prevention & control Probiotics/therapeutic use Prognosis
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
DiBaise John K
Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA. [email protected]
Zhang Husen
Crowell Michael D
Krajmalnik-Brown Rosa
Decker G Anton
Rittmann Bruce E
Article Info
Journal
Mayo Clinic proceedings
Abbr.
Mayo Clin Proc
ISSN
0025-6196
Published
2008-04-00
Pages
460-9
Language
English
Region
England
NLM ID
0405543
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]